Anbioton has been acquired by Elfa Medicamentos
July 2021 — The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.
Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.
Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.
Our role in the transaction
One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.
Talk to the deal team
Related deals
Nymann Kloak- & Miljøservice has been acquired by Serwent Group
Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.
Learn moreDIGMATIX has entered Romania through the acquisition of Elian Solutions
DIGMATIX, one of the largest providers of Microsoft Business Applications solutions in the region, has acquired Elian Solutions, a Romanian Microsoft Dynamics 365 partner, together with its subsidiary Elian Development Systems. Through the acquisition, DIGMATIX expands its operations into Romania and strengthens its position as a regional leader in the implementation and development of Microsoft Business Applications solutions. The acquisition was financed by an investment from DIGMATIX’s majority shareholder, Baltic private equity fund Livonia Partners, together with financing provided by SEB Bank.
Learn moreHeka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn more